Entera Bio Ltd. held its Annual Meeting of Shareholders on July 16, 2025. The election of Haya Taitel to the Board of Directors was approved. The revised compensation terms for Ms. Miranda Toledano and Dr. Gregory Burshtein were ratified and approved. The appointment of Kesselman & Kesselman as the independent auditors for the fiscal year ending December 31, 2025, was ratified and approved. Additionally, the compensation of the named executive officers was ratified and approved on an advisory, non-binding basis.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entera Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-25-002406), on July 18, 2025, and is solely responsible for the information contained therein.